OBJECTIVE: Prospective studies elucidating the impact of the treatment of @entity5 on urinary and climacteric symptoms and sexual life are relatively rare. The aim of this study was to seek information about the occurrence of urinary, climacteric and sexual symptoms in @entity1 with @entity5 before and 1 year after treatment without brachytherapy. METHODS: This prospective study evaluated 39 @entity1 treated for @entity5 . Data were collected by two questionnaires (before and 1 year after treatment). In order to supplement the data from the questionnaires, some data were selected from the @entity1 's medical records. RESULTS: The number of @entity1163 , urgency, @entity322 and climacteric symptoms had not increased 1 year after treatment. Vaginal dryness and @entity546 had @entity458 was reduced 1-year post-treatment. CONCLUSION: This study has shown that urinary and climacteric symptoms are not frequent 1 year after treatment of @entity5 without brachytherapy. However, there is an increased occurrence of vaginal dryness and @entity250 1-year post-treatment, mainly in the form of @entity546 and @entity458 . Taken together these symptoms affect the @entity1 's quality of life and it is, therefore, crucial that the medical providers become more aware of and skilled to deal with these conditions before and after treatment.

Urinary, climacteric and sexual symptoms 1 year after treatment of XXXX without brachytherapy.

@entity1 :: ('9606', 'Species') :: ['women', 'patient'] @entity322 :: ('MESH:D014549', 'Disease') :: ['urinary incontinence'] @entity5 :: ('MESH:D009369', 'Disease') :: ['cervical cancer'] @entity1163 :: ('MESH:D013575', 'Disease') :: ['voluntary micturitions'] @entity458 :: ('MESH:D020018', 'Disease') :: ['reduced sexual desire', 'increased and sexual desire'] @entity546 :: ('MESH:D004414', 'Disease') :: ['dyspareunia'] @entity250 :: ('MESH:D012735', 'Disease') :: ['sexual disorders']
@entity5 :: (MESH:D009369,Disease) :: ['cervical cancer']
